This is a company that have never missed their forecast. Based on their track record, I can only assume $85m over the next three years is a safe bet and one that they will be aiming to not just deliver but hopefully smash. At a 60% margin the discounted cashflow valuation on this must be massive. Looking forward to see an updated analyst report that shows the numbers.
This is a company that have never missed their forecast. Based...
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.5¢ |
Change
0.035(7.00%) |
Mkt cap ! $110.9M | |||
| Open | High | Low | Value | Volume |
| 54.0¢ | 55.5¢ | 51.5¢ | $455.0K | 848.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21544 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 57865 | 3 |
View Market Depth
| Last trade - 12.58pm 29/07/2024 (20 minute delay) ? |
| BIO (ASX) Chart |